Relevance of Liver Enzyme Elevations With Four Different Neuroleptics: A Retrospective Review of 7,263 Treatment Courses
Authors:
- Ines GaertnerIGInes Gaertner
- Kristin AltendorfKAKristin Altendorf
- Anil BatraABAnil Batra
- Hans Jörg GaertnerHGHans Jörg Gaertner
- 1 April 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 21 (2) , 215-222
Abstract
Data on liver enzyme elevations were collected in a retrospective study of 7,263 treatment courses with haloperidol, clozapine, perphenazine, and perazine. Charts of 233 patients hospitalized between 1980 and 1992 at Tübingen University Psychiatric Clinic were selected because clinically relevant increases of liver enzymes had been detected during monotherapy with one of the four examined neuroleptics. At least one hepatic enzyme (mostly alanine aminotransferase [ALAT]) exceeded the established reference range of 3-fold elevations of ALAT, aspartate aminotransferase, γ-glutamyl transpeptidase, and glutamate dehydrogenase and 2-fold elevations of alkaline phosphatase (AP) during monotherapy with clozapine in 15%, perazine in 7.6%, perphenazine in 4%, and haloperidol in 2.4% of the cases. If all liver enzyme abnormalities with any elevation greater than the conventional upper limits are considered, incidences were as follows: clozapine, 78%; perphenazine, 62%; perazine, 59%; and haloperidol, 50%. Testing for overall differences within the four neuroleptics resulted in significantly different incidences of liver enzyme elevations (χ2 test, p < 0.0001). Threefold increases of AP (>540 U/L) were seen in three patients receiving haloperidol (0.3%) only. Twofold increases of AP (>360 U/L) were distributed as follows: clozapine, 1%; haloperidol, 0.8%; perazine, 0.3%; and perphenazine, 0.1%. Only in the group with 1-fold elevations of AP (>180 U/L) were the differences within the drug regimens significant (clozapine, 40.3%; haloperidol, 33.2%; perphenazine, 23.4%; and perazine, 23.1%; χ2 test, p < 0.0001). In the period under study, no instance of icterus occurred.Keywords
This publication has 6 references indexed in Scilit:
- Hepatotoxicity of ClozapineJournal of Clinical Psychopharmacology, 1997
- Fatal acute fulminant liver failure due to clozapine: A case report and review of clozapine-induced hepatotoxicityGastroenterology, 1997
- GENERAL ASPECTS OF DRUG-INDUCED LIVER DISEASEGastroenterology Clinics of North America, 1995
- Side effects of clozapinePsychopharmacology, 1989
- Arzneimittelschäden der LeberDMW - Deutsche Medizinische Wochenschrift, 1985
- Haloperidol-Induced Chronic Cholestatic Liver DiseaseGastroenterology, 1982